CCL Stock Price: Carnival Corp shares soar more than 30% on vaccine optimism
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFER- Carnival Corp stocks are up more than 30% on Monday.
- CCL touched its highest level since early June near $20.
- Pfizer says its coronavirus vaccine is more than 90% effective.
Major equity indexes in the US jumped to fresh all-time highs after the opening bell on Monday as Pfizer's latest report on its experimental coronavirus vaccine revived optimism for an effective treatment.
Pfizer announced on Monday that the vaccine they have been developing with BioNTech was "more than 90%" effective in phase three clinical study, citing results from an external and independent Data Monitoring Committee.
NYSE: CCL
Major cruise liner shares, which suffered heavy losses during the first months of the coronavirus crisis, are posting impressive gains at the start of the week. Carnival Corp (CCL: NYSE) shares are leading the rally, gaining 32.4% on a daily basis at $18.30. Earlier in the session, CCL touched its highest level since early June at $19.86.
Reflecting the impressive performance of the cruise industry, Royal Caribbean Cruises Ltd and Norwegian Cruise Line Holdings Ltd shares are up 30% and 25%, respectively.
In late March, Carnival Corp announced that it has decided to suspend CCL stock dividend and repurchase with an aim to improve liquidity while having its operations halted due to the outbreak. The company also noted that it expects to register a net loss in the fiscal year ending November 30th.
- Carnival Corp stocks are up more than 30% on Monday.
- CCL touched its highest level since early June near $20.
- Pfizer says its coronavirus vaccine is more than 90% effective.
Major equity indexes in the US jumped to fresh all-time highs after the opening bell on Monday as Pfizer's latest report on its experimental coronavirus vaccine revived optimism for an effective treatment.
Pfizer announced on Monday that the vaccine they have been developing with BioNTech was "more than 90%" effective in phase three clinical study, citing results from an external and independent Data Monitoring Committee.
NYSE: CCL
Major cruise liner shares, which suffered heavy losses during the first months of the coronavirus crisis, are posting impressive gains at the start of the week. Carnival Corp (CCL: NYSE) shares are leading the rally, gaining 32.4% on a daily basis at $18.30. Earlier in the session, CCL touched its highest level since early June at $19.86.
Reflecting the impressive performance of the cruise industry, Royal Caribbean Cruises Ltd and Norwegian Cruise Line Holdings Ltd shares are up 30% and 25%, respectively.
In late March, Carnival Corp announced that it has decided to suspend CCL stock dividend and repurchase with an aim to improve liquidity while having its operations halted due to the outbreak. The company also noted that it expects to register a net loss in the fiscal year ending November 30th.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.